Praxis Precision Medicines to report Q1 2026 results on May 7 and present at investor conference May 12

Praxis Precision Medicines will announce its financial results for Q1 2026 on May 7, 2026, before the market opens, followed by a conference call and webcast. The company will also present at the Bank of America Securities Health Care Conference on May 12, 2026. Praxis focuses on developing therapies for central nervous system disorders using genetic insights, with a diversified portfolio including late-stage candidates for movement disorders and epilepsy. Investors can access live and replay webcasts via the company's website.